An observational study in Cannabis Dependence, Harmful Use and Cognitive Assessment, sponsored by University Hospital Pilsen. Recruiting at 1 site in Czechia. Open to participants aged 15 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by University Hospital Pilsen · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Cannabis Abstinence and Neurocognitive Assessment in Adolescence
Evaluate the development of cognitive functions following attainment of abstinence in a group of adolescents with cannabis dependence or harmful cannabis use. Abstinence is confirmed by toxicological testing.
188 studies on the registry are indexed under Marijuana Abuse; 26 are open to participants now.
This study's planned enrollment of 29 is below the median of 100 across 20 observational studies indexed under Marijuana Abuse.
Browse Marijuana Abuse studies →University Hospital Pilsen is the lead sponsor of 10 studies on the registry; 7 are open to participants now.
Compared within Marijuana Abuse, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Adolescents aged 15-18 years with a diagnosis of cannabis dependence or harmful cannabis use.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adolescents aged 15-18 years with a diagnosis of cannabis dependence or harmful cannabis use.
Diagnostic Test: Neurocognitive assessment · Diagnostic Test: Urine toxicological assessment
Neurocognitive battery: TMT-Trail Making Test Auditory Verbal Learning Test Stroop Test Tower of London (ToL), Shallice version Continuous Performance Test-Identical Pairs Other psychometrics: The level of dependence is quantified using the CAST (Cannabis Abuse Screening Test)
Urine toxicological assessment
Change in performance TMT-B
Change in performance on the Trail Making Test - Part B (TMT-B) \[Time Frame: after 8 weeks of abstinence from cannabis\]
Time frame: 8 weeks
Change in performance on AVLT
Change in performance on the Auditory Verbal Learning Test (AVLT) \[Time Frame: after 8 weeks of abstinence\]
Time frame: 8 weeks
Change in performance on the Stroop Test
Change in performance on the Stroop Test \[Time Frame: after 8 weeks of abstinence\]
Time frame: 8 weeks
Change in performance on the Tower of London
Change in performance on the Tower of London (Shallice version) \[Time Frame: after 8 weeks of abstinence\]
Time frame: 8 weeks
Change in performance on CPT-IP
Change in performance on the Continuous Performance Test - Identical Pairs (CPT-IP) \[Time Frame: after 8 weeks of abstinence\]
Time frame: 8 weeks
Cannabis Abuse Screening Test versus degree of neurocognitive impairment
Correlation between severity of cannabis dependence (Cannabis Abuse Screening Test, CAST) and degree of neurocognitive impairment \[Time Frame: baseline and after 8 weeks of abstinence\]
Time frame: 8 weeks
Plan to share: Undecided — Not decided yet because we are still recruiting and waiting for primary outcome.
No publications or documents are linked to this record.
Started Dec 2024 (actual). Primary completion is estimated for Dec 2028, 48 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Pilsen